Clinical Trial

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to conduct a US Pilot study of dMD-002 as a peripheral nerve repair sheet in patients with cavernous nerve injury following radical prostatectomy. The study will determine which endpoints and timepoints will be used for the pivotal study.
Protocol Amendment History 6 changes
critical Trial status changed: Withheld → Not Yet Recruiting 2026-05-16
critical Phase changed: not specified -> Phase 1/2 2026-05-16
critical Primary endpoint(s) modified 2026-05-16
notable Enrollment changed: None -> 30 2026-05-16
notable Sponsor changed: [Redacted] -> Mochida Medical USA, Inc. 2026-05-16
minor Trial arms changed: 0 -> 2 2026-05-16
Trial Details
NCT Number NCT07564102
Lead Sponsor Mochida Medical USA, Inc.
Conditions Prostate Cancer
Enrollment 30 participants
Start Date 2026-08-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-15